• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EIF4A3 诱导的 circTOLLIP 通过 miR-516a-5p/PBX3/EMT 通路促进肝癌的进展。

EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.

机构信息

Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, 430030, Wuhan, Hubei, People's Republic of China.

Hubei Key Laboratory of Hepato-Pancreato-Biliary Diseases, Wuhan, Hubei, People's Republic of China.

出版信息

J Exp Clin Cancer Res. 2022 May 5;41(1):164. doi: 10.1186/s13046-022-02378-2.

DOI:10.1186/s13046-022-02378-2
PMID:35509064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9069765/
Abstract

BACKGROUND

Circular RNAs (circRNAs) function as crucial regulators in multiple cancers, including hepatocellular carcinoma (HCC). However, the roles of circRNAs in HCC remains largely unknown.

METHODS

circTOLLIP was identified in HCC by screening of two public circRNA microarray datasets and detected in HCC cells and tissues through quantitative real-time PCR (qRT-PCR) and in situ hybridization (ISH). Gain- and loss-of-function assays were performed to confirm the biological effects of circTOLLIP on HCC in vitro and in vivo. Mechanistically, bioinformatics analysis of online databases, MS2-RNA pulldown, biotin-labeled circTOLLIP/miR-516a-5p RNA pulldown, RNA immunoprecipitation (RIP), luciferase reporter assay, fluorescence in situ hybridization assay (FISH) and RNA sequencing were used to confirm the regulation of Eukaryotic initiation factor 4A3 (EIF4A3) on circTOLLIP and the interaction among circTOLLIP, miR-516a-5p and PBX homeobox 3 (PBX3).

RESULTS

circTOLLIP was significantly upregulated in HCC cells and tissues. High circTOLLIP expression was correlated with poor overall survival (OS) and disease-free survival (DFS) in patients. circTOLLIP promoted the proliferation and metastasis of HCC cells in vitro and in vivo. Mechanistically, EIF4A3 promoted the biogenesis of circTOLLIP without affecting its stability. Moreover, circTOLLIP sponged miR-516a-5p to elevate the expression of PBX3, thereby activating the epithelial-to-mesenchymal transition (EMT) pathway and facilitating tumor progression in HCC.

CONCLUSIONS

Our findings indicate that EIF4A3-induced circTOLLIP promotes the progression of HCC through the circTOLLIP/miR-516a-5p/PBX3/EMT axis.

摘要

背景

环状 RNA(circRNAs)在多种癌症中作为重要的调控因子发挥作用,包括肝细胞癌(HCC)。然而,circRNAs 在 HCC 中的作用在很大程度上仍然未知。

方法

通过筛选两个公共的 circRNA 微阵列数据集,在 HCC 细胞和组织中通过定量实时 PCR(qRT-PCR)和原位杂交(ISH)检测到 circTOLLIP。体外和体内进行增益和缺失功能测定,以确认 circTOLLIP 对 HCC 的生物学影响。通过在线数据库的生物信息学分析、MS2-RNA 下拉、生物素标记的 circTOLLIP/miR-516a-5p RNA 下拉、RNA 免疫沉淀(RIP)、荧光素酶报告基因测定、荧光原位杂交(FISH)和 RNA 测序来证实真核起始因子 4A3(EIF4A3)对 circTOLLIP 的调控以及 circTOLLIP、miR-516a-5p 和 PBX 同源盒 3(PBX3)之间的相互作用。

结果

circTOLLIP 在 HCC 细胞和组织中显著上调。circTOLLIP 高表达与患者的总生存期(OS)和无病生存期(DFS)不良相关。circTOLLIP 促进 HCC 细胞在体外和体内的增殖和转移。机制上,EIF4A3 促进 circTOLLIP 的生物发生而不影响其稳定性。此外,circTOLLIP 海绵吸附 miR-516a-5p 以提高 PBX3 的表达,从而激活上皮间质转化(EMT)途径并促进 HCC 中的肿瘤进展。

结论

我们的研究结果表明,EIF4A3 诱导的 circTOLLIP 通过 circTOLLIP/miR-516a-5p/PBX3/EMT 轴促进 HCC 的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/66b948e33ff5/13046_2022_2378_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/b692eadbfad7/13046_2022_2378_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/8d147520f4b7/13046_2022_2378_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/caf73bf00ed6/13046_2022_2378_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/ed2c73625487/13046_2022_2378_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/30abe9b665b4/13046_2022_2378_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/ff84fd920d19/13046_2022_2378_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/cb86b5935993/13046_2022_2378_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/66b948e33ff5/13046_2022_2378_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/b692eadbfad7/13046_2022_2378_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/8d147520f4b7/13046_2022_2378_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/caf73bf00ed6/13046_2022_2378_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/ed2c73625487/13046_2022_2378_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/30abe9b665b4/13046_2022_2378_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/ff84fd920d19/13046_2022_2378_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/cb86b5935993/13046_2022_2378_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dd91/9069765/66b948e33ff5/13046_2022_2378_Fig8_HTML.jpg

相似文献

1
EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.EIF4A3 诱导的 circTOLLIP 通过 miR-516a-5p/PBX3/EMT 通路促进肝癌的进展。
J Exp Clin Cancer Res. 2022 May 5;41(1):164. doi: 10.1186/s13046-022-02378-2.
2
EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.EIF4A3 调控的 circ_0087429 通过 miR-5003-3p 依赖性上调 OGN 表达逆转 EMT 并抑制宫颈癌进展。
J Exp Clin Cancer Res. 2022 May 5;41(1):165. doi: 10.1186/s13046-022-02368-4.
3
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.外泌体来源的 circCCAR1 促进肝癌中 CD8+T 细胞功能障碍和抗 PD1 耐药性。
Mol Cancer. 2023 Mar 18;22(1):55. doi: 10.1186/s12943-023-01759-1.
4
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.hsa_circ_0005397 通过 EIF4A3 促进肝癌进展。
BMC Cancer. 2024 Feb 21;24(1):239. doi: 10.1186/s12885-024-11984-6.
5
LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p.长链非编码RNA SNHG12通过miR-516a-5p靶向HEG1促进肝细胞癌的增殖和上皮间质转化。
Cell Signal. 2021 Aug;84:109992. doi: 10.1016/j.cellsig.2021.109992. Epub 2021 Mar 24.
6
EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.EIF4A3 诱导的环状 RNA MMP9(circMMP9)作为 miR-124 的海绵体,促进多形性胶质母细胞瘤细胞的肿瘤发生。
Mol Cancer. 2018 Nov 23;17(1):166. doi: 10.1186/s12943-018-0911-0.
7
Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma.环状泛素样结构域包含植物同源结构域和环指结构域蛋白 1 通过招募真核翻译起始因子 4A3,转录抑制 PDZ 和同源盒蛋白结构域蛋白 1,增加 G9a 和环状泛素样结构域包含植物同源结构域和环指结构域蛋白 1mRNA 的稳定性,从而促进肝癌的转移。
J Gastroenterol Hepatol. 2024 Mar;39(3):596-607. doi: 10.1111/jgh.16408. Epub 2023 Dec 7.
8
Hypoxia-enhanced YAP1-EIF4A3 interaction drives circ_0007386 circularization by competing with CRIM1 pre-mRNA linear splicing and promotes non-small cell lung cancer progression.缺氧增强 YAP1-EIF4A3 相互作用通过与 CRIM1 前体 mRNA 线性剪接竞争驱动 circ_0007386 环化,促进非小细胞肺癌进展。
J Exp Clin Cancer Res. 2024 Jul 20;43(1):200. doi: 10.1186/s13046-024-03116-6.
9
Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.Hsa_circ_0003998 通过海绵吸附 miR-143-3p 和 PCBP1 促进肝癌的上皮间质转化。
J Exp Clin Cancer Res. 2020 Jun 17;39(1):114. doi: 10.1186/s13046-020-01576-0.
10
EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis.EIF4A3 诱导的 circZFAND6 通过 miR-647/FASN 轴促进乳腺癌的增殖和转移。
Life Sci. 2023 Jul 1;324:121745. doi: 10.1016/j.lfs.2023.121745. Epub 2023 Apr 29.

引用本文的文献

1
RNA-Binding Proteins (RBPs) and Circular RNA Biogenesis.RNA结合蛋白(RBPs)与环状RNA的生物合成
Adv Exp Med Biol. 2025;1485:117-130. doi: 10.1007/978-981-96-9428-0_8.
2
Formation of Circular RNAs.环状RNA的形成。
Adv Exp Med Biol. 2025;1485:99-115. doi: 10.1007/978-981-96-9428-0_7.
3
PBX3-HMGCR Axis Promotes Hepatocellular Carcinoma Progression Through Enhancing De Novo Cholesterol Biosynthesis.PBX3-HMGCR轴通过增强从头胆固醇生物合成促进肝细胞癌进展。

本文引用的文献

1
Effect of eukaryotic translation initiation factor 4A3 in malignant tumors.真核生物翻译起始因子4A3在恶性肿瘤中的作用。
Oncol Lett. 2021 May;21(5):358. doi: 10.3892/ol.2021.12619. Epub 2021 Mar 8.
2
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
3
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.
Int J Mol Sci. 2025 May 29;26(11):5210. doi: 10.3390/ijms26115210.
4
EIF4A3 enhances the viability, invasion and osteogenic differentiation of BMSCs via the USP53/SMAD5 pathway.EIF4A3通过USP53/SMAD5途径增强骨髓间充质干细胞的活力、侵袭能力和成骨分化能力。
Sci Rep. 2025 Jun 6;15(1):19979. doi: 10.1038/s41598-025-86048-1.
5
PHAX enhanced LIN28B-mediated PBX3 mRNA stability to promote esophageal cancer development.PHAX增强LIN28B介导的PBX3 mRNA稳定性以促进食管癌发展。
Cancer Sci. 2025 Mar;116(3):808-823. doi: 10.1111/cas.16420. Epub 2024 Dec 12.
6
The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications.剪接异构体与环状 RNA 在癌症中的相互作用:发病机制见解和治疗意义。
Cell Mol Biol Lett. 2024 Nov 16;29(1):142. doi: 10.1186/s11658-024-00662-x.
7
N-methyladenosine modification of circular RNA circASH2L suppresses growth and metastasis in hepatocellular carcinoma through regulating hsa-miR-525-3p/MTUS2 axis.环状 RNA circASH2L 的 N6-甲基腺苷修饰通过调节 hsa-miR-525-3p/MTUS2 轴抑制肝癌的生长和转移。
J Transl Med. 2024 Nov 14;22(1):1026. doi: 10.1186/s12967-024-05745-z.
8
MicroRNAs in Hepatocellular Carcinoma: Insights into Regulatory Mechanisms, Clinical Significance, and Therapeutic Potential.肝细胞癌中的微小RNA:对调控机制、临床意义及治疗潜力的见解
Cancer Manag Res. 2024 Oct 19;16:1491-1507. doi: 10.2147/CMAR.S477698. eCollection 2024.
9
CircHIPK2 Contributes Cell Growth in Intestinal Epithelial of Colitis and Colorectal Cancer through Promoting TAZ Translation.环状 RNA HIPK2 通过促进 TAZ 翻译促进结肠炎和结直肠癌肠道上皮细胞的生长。
Adv Sci (Weinh). 2024 Sep;11(34):e2401588. doi: 10.1002/advs.202401588. Epub 2024 Jul 9.
10
EIF4A3-Induced Circ_0059914 Promoted Angiogenesis and EMT of Glioma via the miR-1249/VEGFA Pathway.EIF4A3诱导的Circ_0059914通过miR-1249/VEGFA途径促进胶质瘤的血管生成和上皮-间质转化
Mol Neurobiol. 2025 Jan;62(1):973-987. doi: 10.1007/s12035-024-04319-w. Epub 2024 Jul 1.
局部区域治疗在肝癌的分子和免疫治疗时代。
Nat Rev Gastroenterol Hepatol. 2021 May;18(5):293-313. doi: 10.1038/s41575-020-00395-0. Epub 2021 Jan 28.
4
cFUT8 promotes liver cancer progression by miR-548c/FUT8 axis.cFUT8通过miR-548c/FUT8轴促进肝癌进展。
Signal Transduct Target Ther. 2021 Jan 27;6(1):30. doi: 10.1038/s41392-020-00393-3.
5
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
6
MiRNA-516a promotes bladder cancer metastasis by inhibiting MMP9 protein degradation via the AKT/FOXO3A/SMURF1 axis.微小RNA-516a通过AKT/FOXO3A/SMURF1轴抑制基质金属蛋白酶9(MMP9)蛋白降解来促进膀胱癌转移。
Clin Transl Med. 2020 Dec;10(8):e263. doi: 10.1002/ctm2.263.
7
EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1-2 signaling.EIF4A3诱导的环状RNA ASAP1通过NRAS/MEK1/ERK1-2信号通路促进胶质母细胞瘤的肿瘤发生和替莫唑胺耐药。
Neuro Oncol. 2021 Apr 12;23(4):611-624. doi: 10.1093/neuonc/noaa214.
8
MG132 inhibits the expression of PBX3 through miRNAs by targeting Argonaute2 in hepatoma cells.MG132通过在肝癌细胞中靶向AGO2,经微小RNA抑制PBX3的表达。
Saudi J Biol Sci. 2020 Aug;27(8):2157-2163. doi: 10.1016/j.sjbs.2020.06.008. Epub 2020 Jun 16.
9
Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.Hsa_circ_0003998 通过海绵吸附 miR-143-3p 和 PCBP1 促进肝癌的上皮间质转化。
J Exp Clin Cancer Res. 2020 Jun 17;39(1):114. doi: 10.1186/s13046-020-01576-0.
10
Emerging biomarkers in HCC patients: Current status.肝癌患者的新兴生物标志物:现状。
Int J Surg. 2020 Oct;82S:70-76. doi: 10.1016/j.ijsu.2020.04.043. Epub 2020 Apr 25.